NCT03719313 — Hepatitis Delta Virus trial site landscape

Public-registry site landscape for NCT03719313, a Hepatitis Delta Virus study sponsored by Eiger BioPharmaceuticals. All data below is from public sources; Eichor is not affiliated with the sponsor.

Trial	NCT03719313 (registry record)
Sponsor	Eiger BioPharmaceuticals
Condition(s)	Hepatitis Delta Virus
Phase	PHASE3
Listed sites	116
Site countries	United States, Belgium, Bulgaria, Canada, France, Germany, Greece, Israel, Italy, Moldova, Mongolia, New Zealand

Free site-risk snapshot for this trial

Eichor generates a preliminary site-risk snapshot for NCT03719313 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →

Planning or rescuing a trial? Eichor generates evidence-linked site-risk reports from public data in minutes. Get a free preliminary snapshot →
Launch offer through July 31: first full site unlock free — one per company.